- Home
- MNPR vs GCBC Comparison
MNPR vs GCBC Comparison
Compare MNPR & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- GCBC
- Stock Information
- Founded
- MNPR 2014
- GCBC 1889
- Country
- MNPR United States
- GCBC United States
- Employees
- MNPR N/A
- GCBC N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- GCBC Banks
- Sector
- MNPR Health Care
- GCBC Finance
- Exchange
- MNPR Nasdaq
- GCBC Nasdaq
- Market Cap
- MNPR 390.5M
- GCBC 391.6M
- IPO Year
- MNPR 2019
- GCBC 1998
- Fundamental
- Price
- MNPR $99.37
- GCBC $22.58
- Analyst Decision
- MNPR Strong Buy
- GCBC
- Analyst Count
- MNPR 12
- GCBC 0
- Target Price
- MNPR $89.82
- GCBC N/A
- AVG Volume (30 Days)
- MNPR 78.9K
- GCBC 17.2K
- Earning Date
- MNPR 11-07-2025
- GCBC 10-21-2025
- Dividend Yield
- MNPR N/A
- GCBC 1.75%
- EPS Growth
- MNPR N/A
- GCBC 26.12
- EPS
- MNPR N/A
- GCBC 1.83
- Revenue
- MNPR N/A
- GCBC $73,428,000.00
- Revenue This Year
- MNPR N/A
- GCBC N/A
- Revenue Next Year
- MNPR N/A
- GCBC N/A
- P/E Ratio
- MNPR N/A
- GCBC $12.64
- Revenue Growth
- MNPR N/A
- GCBC 14.52
- 52 Week Low
- MNPR $4.50
- GCBC $20.00
- 52 Week High
- MNPR $105.00
- GCBC $35.34
- Technical
- Relative Strength Index (RSI)
- MNPR 88.79
- GCBC 42.62
- Support Level
- MNPR $72.41
- GCBC $21.41
- Resistance Level
- MNPR $105.00
- GCBC $22.90
- Average True Range (ATR)
- MNPR 7.21
- GCBC 0.79
- MACD
- MNPR 2.86
- GCBC -0.09
- Stochastic Oscillator
- MNPR 89.52
- GCBC 25.76
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.